Baxter International Inc vs T-Rex 2X Long MSTR Daily Target ETF — how do they compare? Baxter International Inc trades at $27.17 (market cap $14.27B), while T-Rex 2X Long MSTR Daily Target ETF trades at $1.82. The key difference: Baxter International Inc pays a 0.14% dividend while T-Rex 2X Long MSTR Daily Target ETF pays none, and Baxter International Inc is trading nearer its 52-week high, T-Rex 2X Long MSTR Daily Target ETF nearer its low. Which is the better fit depends on your goals.
| BAX | MSTU | |
|---|---|---|
Market Cap | $14.27B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $28.35 | $76.30 |
52-Week Low | $15.80 | $1.46 |
Enterprise Value | $21.79B | — |
Dividend Yield | 0.14% | — |
Signals from Pluang's Aura AI — not financial advice
Baxter International (BAX) trades at $27.09, down 2.48% today but showing strong technical momentum with bullish moving averages and recent earnings beats. The company reported Q2 2026 EPS of $0.56, beating expectations by 53%, and raised full-year guidance. Despite negative net margins and elevated P/E ratio of 87.85, improving operational performance and positive cash flow projections for 2026 suggest potential turnaround.
The stock presents a mixed outlook with strong technical momentum and recent operational improvements offset by valuation concerns and profitability challenges. Key opportunities include continued execution on raised guidance and debt reduction efforts, while risks center on margin pressure and high debt levels. Analyst consensus leans neutral with 55.55% hold ratings and $25.43 price target below current levels.
MSTU, a leveraged ETF tracking MicroStrategy (MSTR), trades at $1.815, down 3.97% on the day, reflecting severe long-term erosion. The technical outlook is bearish with moving averages signaling strong selling pressure, while oscillators remain neutral. Recent news highlights catastrophic losses, including a 98% decline from 2024 levels, exacerbated by a 10:1 reverse stock split effective August 24, 2026.
The outlook for MSTU is highly risky due to leveraged decay and dependency on MSTR's volatile performance. Investment opportunities are minimal given the fund's history of value destruction, with risks including daily rebalancing losses, crypto market exposure, and lack of fundamental company metrics. Caution is paramount for potential investors.
Trailing returns across standard periods
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.
Read more on BAX →MSTU is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bullish (long) position in MSTR, a company known for its significant Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on MSTU →